Health & Wellness
Semaglutide vs. Tirzepatide vs. Retatrutide: What the Trial Data Actually Shows
Three GLP-1-class peptides, three different receptor targets, and three very different regulatory outcomes — a source-backed comparison of what each drug's actu…